TickerFactsScreenerDevelopers

BIOCRYST PHARMACEUTICALS INC (BCRX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $22.34M2009: $41.12M2010: $13.62M2011: $16.44M2012: $20.89M2013: $21.16M2014: $54.54M2015: $28.90M2016: $22.10M2017: $50.28M2018: $26.73M2019: $114.17M2020: $272.13M2021: $504.39M2022: $304.77M2023: $110.64M2024: $104.71M2025: $89.74M$89.74M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$89.74M-14.3%
2024$104.71M-5.4%
2023$110.64M-63.7%
2022$304.77M-39.6%
2021$504.39M+85.4%
2020$272.13M+138.3%
2019$114.17M+327.1%
2018$26.73M-46.8%
2017$50.28M+127.5%
2016$22.10M-23.5%
2015$28.90M-47.0%
2014$54.54M+157.7%
2013$21.16M+1.3%
2012$20.89M+27.0%
2011$16.44M+20.7%
2010$13.62M-66.9%
2009$41.12M+84.1%
2008$22.34M—